欧洲疾控中心：2025年呼吸道合胞病毒疫苗的有效性和安全性活体系统综述和元分析报告（英文版）

Respiratory syncytial virus (RSV) is a prevalent and pervasive highly transmissible virus within the family Pneumoviridae, leading to respiratory illness of varying severity in humans. Most individuals experience their initial infection during early childhood, with near universal exposure by age two. Since the discovery of RSV in 1956, vaccine development for the disease has been a major global health priority. Several clinical trials have taken place for nanoparticle-based and virus-like par